Food Allergen Thresholds of Reactivity

Food Allergy: Adverse Reactions to Foods and Food Additives, Fourth Edition

Volumn , Issue , 2009, Pages 82-89

  Taylor, Steve L ^a   Hourihane, Jonathan O'B ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

"Allergen free" products in markets; Allergic responses sensitization and elicitation phases; Clinical trials using low dose challenges; Double blind, placebo controlled food challenge (DBPCFC); Food allergen thresholds of reactivity; Food industry and threshold information regulatory uses; Governmental regulatory agencies and population based thresholds

Indexed keywords

EID: 67349281405     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300062.ch6     Document Type: Chapter

References (54)

1. Gem JE, Yang E, Evrard HM, et al. Allergic reactions to milk-contaminated "non-dairy" products. N Engl J Med 1991;324:976-9.
2. Yman IM. Detection of inadequate labeling and contamination as causes of allergic reactions to foods. Acta Aliment 2004;33:347-57.
3. Taylor SL, Hefle SL, Bindslev-Jensen C, et al. Factors affecting the determination of threshold doses for allergenic foods: How much is too much? J Allergy Clin Immunol 2002;109:24-30.
4. Hefle SL, Taylor SL. How much food is too much? Threshold doses for allergenic foods. Curr Allergy Asthma Reps 2002;2:63-66.
5. Sampson HA. Epidemiology of food allergy. Pediatr Allergy Immunol 1996;7:42-50.
6. Leung DYM, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003;348:986-93.
7. Morisset M, Moneret-Vautrin DA, Kanny G, et al. Thresholds of clinical reactivity to milk, egg, peanut and sesame in immunoglobulin E-dependent allergies: evaluation by double-blind or single-blind placebo-controlled oral challenges. Clin Exp Allergy 2003;33:1046-51.
8. Crevel RWR, Briggs D, Hefle SL, et al. Hazard characterization in food allergen risk assessment: the application of statistical approaches and the use of clinical data. Food Chem Toxicol 2007;45:691-701.
9. Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 1988;82:986-97.
10. Lack G, Fox D, Northstone K, et al. Factors associated with the development of peanut allergy in childhood. N Eng J Med 2003;348:977-85.
11. Strid J, Hourihane J, Kimber I, et al. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 2004;34:2100-9.
12. Adel-Patient K, Ah-Leung S, Bernard H, et al. Oral sensitization to peanut is highly enhanced by application of peanut extracts to intact skin, but is prevented when CpG and cholera toxin are added. Int Arch Allergy Immunol 2007;143:10-20.
13. Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, et al. Standardization of food challenges in patients with immediate reactions to foods-position paper from the European Academy of Allergology and Clinical Immunology. Allergy 2004;59:690-7.
14. Hourihane J, Kilburn SA, Nordlee JA, et al. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 1997;100:596-600.
15. Taylor SL, Hefle SL, Bindslev-Jensen C, et al. A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy 2004;34:689-95.
16. Flinterman AE, Pasmans SG, Hoekstra MO, et al. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children. J Allergy Clin Immunol 2006;117:448-54.
17. Hourihane JO'B, Knulst AC. Thresholds of allergenic proteins in foods. Toxicol Appl Pharmacol 2005;207:152-6.
18. Hourihane JO'B, Grimshaw KE, Lewis SA, et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? Clin Exp Allergy 2005;35:1227-33.
19. Nordlee JA, Hefle SL, Taylor SL, et al. Minimum elicitation dose determination using roasted peanut-low dose challenges. J Allergy Clin Immunol 2007;119:S158.
20. Grimshaw KEC, King RM, Nordlee JA, et al. Presentation of allergen in different food preparations affects the nature of the allergic reaction-a case series. Clin Exp Allergy 2003;33:1581-5.
21. van der Zee JA, Wensing M, Penninks AH, et al. Threshold levels in peanut and hazelnut allergic patients do not change over time. Proceedings of XXII Congress of European Academy of Allergology and Clinical Immunology, Paris, 2003.
22. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004;113:805-19.
23. Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 2005;115:1291-6.
24. Peeters KABM, Koppelman S, van Hoffen E, et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy 2007;37:108-15.
25. Wensing M, Penninks AH, Hefle SL, et al. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. J Allergy Clin Immunol 2002;110:915-20.
26. Sicherer SH, Morrow EH, Sampson HA. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2000;105:582-6.
27. Perry TT, Matsu EC, Conover-Walker MK, et al. Risk of oral food challenges. J Allergy Clin Immunol 2004;114:1164-8.
28. Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992;90:256-62.
29. Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:744-51.
30. Lewis SA, Grimshaw KEC, Warner JO, et al. The promiscuity of immunoglobulin E binding to peanut allergens, as determined by Western blotting, correlates with the severity of clinical symptoms. Clin Exp Allergy 2005;35:767-73.
31. Moneret-Vautrin DA, Rance F, Kanny G, et al. Food allergy to peanuts in France-evaluation of 142 observations. Clin Exp Allergy 1998;28:1113-19.
32. May CD. Objective clinical and laboratory studies of immediate hypersensitivity reactions to foods in asthmatic children. J Allergy Clin Immunol 1976;58:500-15.
33. Meglio P, Bartone E, Plantamura M, et al. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004;59:980-7.
34. Moneret-Vautrin DA, Fremont S, Kanny G, et al. The use of two multitests fx5 and fx10 in the diagnosis of food allergy in children: regarding 42 cases. Allergie Immunologie 1995;27:2-6.
35. Fiocchi A, Travaini M, D'Auria E, et al. Tolerance to a rice hydrolysate formula in children allergic to cow's milk and soy. Clin Exp Allergy 2003;33:1576-80.
36. Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007;119:199-205.
37. Wensing M, Penninks AH, Hefle SL, et al. The range of minimum provoking doses in hazelnut-allergic patients as determined by double-blind, placebo-controlled food challenges. Clin Exp Allergy 2002;32:1757-62.
38. Ispano M, Ansaloni R, Rotondo F, et al. Double blind placebo controlled food (DBPCFC) challenge in subjects believed to be allergic to hazelnut. Abstract of the 7th International Symposium on Immunological, Chemical and Clinical Problems of Food Allergy, Taormina, Italy, Munksgaard, Copenhagen, 1998:92.
39. Flinterman AE, Hoekstra MO, Meijer Y, et al. Clinical reactivity to hazelnut in children: association with sensitization to birch pollen or nuts? J Allergy Clin Immunol 2006;118:1186-9.
40. Magnolfi CF, Zani G, Lacava L, et al. Soy allergy in atopic children. Ann Allergy Asthma Immunol 1996;77:197-201.
41. Rance F, Dutau G, Abbal M. Mustard allergy in children. Allergy 2000;55:496-500.
42. Figueroa J, Blanco C, Dumpierrez AG, et al. Mustard allergy confirmed by double-blind placebo-controlled food challenges: clinical features and cross-reactivity with mugwort pollen and plant-derived foods. Allergy 2005;60:48-55.
43. Hansen TK, Bindslev-Jensen C. Codfish allergy in adults-identification and diagnosis. Allergy 1992;47:610-17.
44. Helbling A, Haydel R, McCants ML, et al. Fish allergy: Is crossreactivity among fish species relevant? Double-blind placebo-controlled food challenge studies in fish allergic adults. Ann Allergy Asthma Immunol 1999;83:517-23.
45. Atkins FM, Steinberg SS, Metcalfe DD. Evaluation of immediate adverse reactions to food in adult patients. II. A detailed analysis of reaction patterns during oral food challenge. J Allergy Clin Immunol 1985;75:356-63.
46. Bernstein M, Day JH, Welsh A. Double-blind food challenge in the diagnosis of food sensitivity in the adult. J Allergy Clin Immunol 1982;70:205-10.
47. Rolinck-Werninghaus C, Staden U, Mehl A, et al. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy. Allergy 2005;60:1320-2.
48. Eriksson NE, Moller C, Werner S, et al. The hazards of kissing when you are food allergic. J Invest Allergol Clin Immunol 2003;13:149-54.
49. Hallett R, Haapanen LAD, Teuber SS. Food allergies and kissing. N Engl J Med 2002;346:1833-4.
50. Sicherer SH, Furlong TJ, DeSimone J, et al. Self-reported allergic reactions to peanut on commercial airlines. J Allergy Clin Immunol 1999;104:186-9.
51. Perry TT, Conover Walker MK, Pomes A, et al. Distribution of peanut allergen in the environment. J Allergy Clin Immunol 2004;113:973-6.
52. Koppelman SJ, Hefle SL (eds.). Detecting Allergens in Food. Cambridge, England: Woodhead Publishing Ltd, 2006:422 pp.
53. Hefle SL, Furlong TJ, Niemann L, et al. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J. Allergy Clin Immunol 2007;120:171-6.
54. Collin P, Thorell L, Kaukinen K, et al. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004;19:1277-83.